SHIELD is designed to support a broad range of operational environments, spanning national public health systems, hospitals and laboratory networks, military and civil defense organizations, humanitarian and NGO response operations, as well as critical infrastructure and remote field deployments. The platform also enables autonomous BSL-3 and BSL-4 laboratory operations, supporting high-containment environments where speed, coordination, and biological security are critical.
The platform integrates directly with Prepaire Labs’ wider biological infrastructure ecosystem, including GenetiQ™ Digital Twin systems, HAiLO™ AI-driven countermeasure workflows, Shield Sentinel™ pathogen sequencing kits, autonomous field laboratories and UAV logistics systems, as well as federated SPARK™ sovereign intelligence nodes.
Professor Min Park, Co-Founder of Prepaire Labs, said: “The world has spent decades building systems that report outbreaks after the fact. SHIELD was built to reduce the time between signal detection and operational response. We believe biological preparedness will become one of the defining infrastructure challenges of the next decade. Faster intelligence, faster sequencing, and faster coordination are now essential capabilities. Platforms like SHIELD represent a major step toward integrated preparedness infrastructure.”
The platform’s architecture allows hospitals and frontline facilities to participate in Shield’s preparedness network without requiring sensitive patient data to leave local environments.
Hospitals and NGOs can deploy Shield Core as a preparedness layer while selectively activating advanced capabilities such as Digital Twins, pharmacogenomic analysis, pathogen sequencing, and HAiLO-driven therapeutic workflows.
Prepaire Labs also announced a humanitarian access framework for qualified NGOs and outbreak response organizations, allowing approved field operators to use Shield in resource-limited environments while contributing governed pathogen and epidemiological intelligence back into the network.
The company stated that the long-term objective is to create a globally distributed biological intelligence infrastructure capable of improving outbreak readiness, accelerating therapeutic development, and reducing response latency during future biological emergencies.
SHIELD is now available for sovereign, enterprise, hospital, and humanitarian deployment.
